BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31497534)

  • 1. The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment.
    Zhong H; Men K; Wang J; van Soest J; Rosenthal D; Dekker A; Zhang Z; Xiao Y
    Front Oncol; 2019; 9():792. PubMed ID: 31497534
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of deviations in target volume delineation - Time for a new RTQA approach?
    Cox S; Cleves A; Clementel E; Miles E; Staffurth J; Gwynne S
    Radiother Oncol; 2019 Aug; 137():1-8. PubMed ID: 31039468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG).
    Lukovic J; Moore AJ; Lee MT; Willis D; Ahmed S; Akra M; Hortobagyi E; Kron T; Lim Joon D; Liu A; Ryan J; Thomas M; Wall K; Ward I; Wiltshire KL; O'Callaghan CJ; Wong RKS; Ringash JG; Haustermans K; Leong T
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1096-1106. PubMed ID: 37393022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial.
    Brade AM; Wenz F; Koppe F; Lievens Y; San Antonio B; Iscoe NA; Hossain A; Chouaki N; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):927-934. PubMed ID: 29976505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between radiotherapy protocol variations and outcome in the CONVERT trial.
    Mir R; Groom N; Mistry HB; Wilson E; Faivre-Finn C
    Clin Transl Radiat Oncol; 2023 Mar; 39():100560. PubMed ID: 36578530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
    Melidis C; Bosch WR; Izewska J; Fidarova E; Zubizarreta E; Ulin K; Ishikura S; Followill D; Galvin J; Haworth A; Besuijen D; Clark CH; Miles E; Aird E; Weber DC; Hurkmans CW; Verellen D
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1242-9. PubMed ID: 25539374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
    Mir R; Kelly SM; Xiao Y; Moore A; Clark CH; Clementel E; Corning C; Ebert M; Hoskin P; Hurkmans CW; Ishikura S; Kristensen I; Kry SF; Lehmann J; Michalski JM; Monti AF; Nakamura M; Thompson K; Yang H; Zubizarreta E; Andratschke N; Miles E
    Radiother Oncol; 2020 Sep; 150():30-39. PubMed ID: 32504762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure.
    Christiaens M; Collette S; Overgaard J; Gregoire V; Kazmierska J; Castadot P; Giralt J; Grant W; Tomsej M; Bar-Deroma R; Monti AF; Hurkmans CW; Weber DC
    Radiother Oncol; 2017 Jun; 123(3):424-430. PubMed ID: 28478912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
    Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
    Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial Evaluation of a Novel Cone-Beam CT-Based Semi-Automated Online Adaptive Radiotherapy System for Head and Neck Cancer Treatment - A Timing and Automation Quality Study.
    Yoon SW; Lin H; Alonso-Basanta M; Anderson N; Apinorasethkul O; Cooper K; Dong L; Kempsey B; Marcel J; Metz J; Scheuermann R; Li T
    Cureus; 2020 Aug; 12(8):e9660. PubMed ID: 32923257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The radiotherapy quality assurance gap among phase III cancer clinical trials.
    Corrigan KL; Kry S; Howell RM; Kouzy R; Jaoude JA; Patel RR; Jhingran A; Taniguchi C; Koong AC; McAleer MF; Nitsch P; Rödel C; Fokas E; Minsky BD; Das P; Fuller CD; Ludmir EB
    Radiother Oncol; 2022 Jan; 166():51-57. PubMed ID: 34838891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer.
    Nelms BE; Tomé WA; Robinson G; Wheeler J
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):368-78. PubMed ID: 21123004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives.
    de Rojas T; Clementel E; Giralt J; Cruz O; Boterberg T; Kortmann RD; Gaze MN; Moreno L; Janssens GO;
    Eur J Cancer; 2019 Jun; 114():36-46. PubMed ID: 31035085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control review for radiotherapy of small breast cancer: analysis of 708 patients in the GBSG I trial. German Breast Study Group (GBSG).
    Seegenschmiedt MH; Sauerbrei W; Sauer R; Schumacher M; Schauer A; Rauschecker HF; Dinkloh H; Dühmke E; Haase KD; Haase W
    Strahlenther Onkol; 1993 Jun; 169(6):339-50. PubMed ID: 8316938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving target volume delineation in intact cervical carcinoma: Literature review and step-by-step pictorial atlas to aid contouring.
    Eminowicz G; Hall-Craggs M; Diez P; McCormack M
    Pract Radiat Oncol; 2016; 6(5):e203-e213. PubMed ID: 27032573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans-Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise.
    Cloak K; Jameson MG; Paneghel A; Wiltshire K; Kneebone A; Pearse M; Sidhom M; Tang C; Fraser-Browne C; Holloway LC; Haworth A
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):390-398. PubMed ID: 30950223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of radiation therapy for unresected soft-tissue sarcomas.
    Kepka L; DeLaney TF; Suit HD; Goldberg SI
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):852-9. PubMed ID: 16199316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
    Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring energy response for RTQA radiochromic film to improve quality assurance procedures.
    Butson MJ; Cheung T; Yu PK
    Australas Phys Eng Sci Med; 2008 Sep; 31(3):203-6. PubMed ID: 18946978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.